NCT07098832尚未招募不适用
Application of Multimodal Biomarkers in Early Diagnosis and Progression Prediction of Diabetic Retinopathy: A Prospective Cohort Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 1,538
- 试验地点
- 1
- 主要终点
- The progression of diabetic retinopathy during the follow-up period.
研究概览
简要总结
The goal of this observational study is to enroll diabetic patients with diabetic retinopathy and those without diabetic retinopathy, follow up and observe the long-term changes in ocular structure and function of the subjects by comparison, analyze their association with multimodal biomarkers, and explore new methods for the early diagnosis and risk prediction of diabetic retinopathy.
Participants will be followed up over a 5-year follow-up period, during which they will undergo ophthalmic examinations, blood tests, and questionnaires.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Participants must understand the clinical trial, voluntarily participate, and sign the informed consent form.
- •Aged 18-80 years, with no restriction on gender.
- •Healthy control group: No history or diagnosis of diabetes.
- •Diabetic group:
- •i) Definite diagnosis of diabetes. Both type 1 and type 2 diabetic patients will be included in this study.
- •ii) Based on dilated fundus examination, subjects are classified into NDR, NPDR, and PDR groups according to the staging of diabetic retinopathy.
- •Idiopathic epiretinal membrane (iERM) group is set as the control group for intraocular specimen collection and analysis in PDR patients: Funduscopic examination shows gold foil-like reflection or glass membrane-like substance covering the macular area, causing local retinal folds, with or without tortuosity and deformation of small perimacular blood vessels; OCT examination reveals a hyperreflective band on the retinal surface of the macular area; meeting the indications for pars plana vitrectomy combined with internal limiting membrane-epiretinal membrane peeling: visual acuity < 0.3, or visual acuity > 0.5 but accompanied by progressive vision loss, severe metamorphopsia, diplopia, visual field defect, or other symptoms that significantly affect quality of life, and surgical treatment can be performed if actively requested by the patient; no diagnosis or history of diabetes.
排除标准
- •Complicated with other severe ocular diseases (e.g., glaucoma, age-related macular degeneration, uveitis, etc.).
- •A history of previous ocular surgery.
- •Complicated with severe systemic diseases (e.g., ischemic heart disease, stroke, malignant tumor, and severe liver or kidney diseases) or a history of systemic surgery (e.g., coronary artery bypass grafting, arterial/venous thrombolysis, organ transplantation, etc.).
- •Complicated with cognitive impairment (MMSE score < 24), mental illness (e.g., schizophrenia, bipolar disorder), or inability to cooperate with questionnaires and ophthalmic examinations due to language comprehension deficits.
结局指标
主要结局
The progression of diabetic retinopathy during the follow-up period.
时间窗: From baseline to study completion, an average of 5 years.
次要结局
- Changes in best-corrected visual acuity during the follow-up period.(From baseline to study completion, an average of 5 years.)
- Blood and intraocular fluid metabolite concentrations measured by metabolomics during follow-up.(From baseline to study completion, an average of 5 years.)
- Changes in ocular functional indicators during the follow-up period.(From baseline to study completion, an average of 5 years.)
- Changes in ocular fundus structure during follow-up as indicated by optical coherence tomography (OCT) examination.(From baseline to study completion, an average of 5 years.)
- Changes in ocular fundus blood flow during follow-up by optical coherence as indicated by tomography angiography (OCTA) examination.(From baseline to study completion, an average of 5 years.)
- Blood and intraocular fluid protein concentrations measured by proteomics during follow-up.(From baseline to study completion, an average of 5 years.)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Biomarkers of Diabetic Retinopathy ProgressionType 2 Diabetes MellitusMild Nonproliferative Diabetic RetinopathyNCT01607190Association for Innovation and Biomedical Research on Light and Image200
已完成
不适用
Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA SequencingProliferative Diabetic RetinopathyDiabetic MaculopathyCirculating Endothelial CellsDiabetesDiabetes MellitusNCT05169502Aarhus University Hospital40
招募中
不适用
DFC 004 Biomarkers for Active Diabetic Foot UlcersDiabetic FootDiabetesDiabetic Foot UlcerNCT06104969University of Michigan5,000
Unknown
不适用
A Multi-center Study on the Artificial Intelligence Enabled Diabetic Retinopathy Screening Based on Fundus ImagesDiabetic RetinopathyNCT03602989Shenzhen SiBright Co., Ltd.1,000
已完成
3 期
The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECTProliferative Diabetic RetinopathyNCT02157350Odense University Hospital65